User profiles for F.A. Angarita
Fernando A. Angarita, MD, MSc, FRCSCUniversity of Toronto / Roswell Park Comprehensive Cancer Center Verified email at mail.utoronto.ca Cited by 1537 |
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans
…, TH Hwang, J Heo, M Cho, H Chen, FA Angarita… - Cancer research, 2013 - AACR
Efforts to selectively target and disrupt established tumor vasculature have largely failed to
date. We hypothesized that a vaccinia virus engineered to target cells with activation of the ras…
date. We hypothesized that a vaccinia virus engineered to target cells with activation of the ras…
Robot-assisted nipple-sparing mastectomy: systematic review
Background The growing volume of studies of robot-assisted nipple-sparing mastectomy
requires critical assessment. This review synthesizes the data on safety, feasibility, oncological …
requires critical assessment. This review synthesizes the data on safety, feasibility, oncological …
Management of complex polyps of the colon and rectum
FA Angarita, AE Feinberg, SM Feinberg… - International journal of …, 2018 - Springer
Puprpose Benign polyps that are technically challenging and unsafe to remove via
polypectomy are known as complex polyps. Concerns regarding safety and completeness of …
polypectomy are known as complex polyps. Concerns regarding safety and completeness of …
[HTML][HTML] Abundance of regulatory T cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer
Simple Summary Regulatory CD4 + T cell (Treg) is one of the suppressive immune cells, but
data on its clinical relevance in large human breast cancer cohort is limited. Abundance of …
data on its clinical relevance in large human breast cancer cohort is limited. Abundance of …
Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses
FA Angarita, SA Acuna, K Ottolino-Perry… - Trends in molecular …, 2013 - cell.com
Blood supply within a tumor drives progression and ultimately allows for metastasis. Many
anticancer therapies target tumor vasculature, but their individual effectiveness is limited …
anticancer therapies target tumor vasculature, but their individual effectiveness is limited …
[PDF][PDF] VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection
R Arulanandam, C Batenchuk, FA Angarita… - Cancer Cell, 2015 - cell.com
Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor
vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia …
vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia …
[HTML][HTML] Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature
Background Primary neuroendocrine carcinoma of the breast is a heterogeneous group of
rare tumors with positive immunoreactivity to neuroendocrine markers in at least 50% of cells. …
rare tumors with positive immunoreactivity to neuroendocrine markers in at least 50% of cells. …
[HTML][HTML] Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
Cancer-associated adipocytes are known to cause inflammation; however, the role of
adipogenesis, the formation of adipocytes, in breast cancer is unclear. We hypothesized that intra-…
adipogenesis, the formation of adipocytes, in breast cancer is unclear. We hypothesized that intra-…
[HTML][HTML] Degree of early estrogen response predict survival after endocrine therapy in primary and metastatic ER-positive breast cancer
Simple Summary Over 70% of breast cancer patients in the US have estrogen receptor (ER)-positive
tumors. A better predictive biomarker of endocrine therapy would be useful to …
tumors. A better predictive biomarker of endocrine therapy would be useful to …
[HTML][HTML] Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple …
Patients with triple negative breast cancer (TNBC) have a poor prognosis. A novel prognostic
biomarker may guide management by appropriately selecting patients for particular …
biomarker may guide management by appropriately selecting patients for particular …